Even as Berkshire Hathaway enters a new chapter, the enduring value of Warren Buffett's investment philosophy shines through in two financial sector holdings—Ally Financial and Jefferies Financial—that analysts see as compelling opportunities this February.
For aspiring homeowners, where to park down payment savings is a critical calculation. With interest rates in flux, the choice between accessible high-yield accounts and locked-in CDs can significantly impact your timeline and final sum.
The explosive growth of artificial intelligence and data centers is driving U.S. electricity demand to unprecedented levels, pushing consumer bills up 42% in a decade. As utilities scramble to upgrade an overburdened grid, AI itself is emerging as a critical tool to unlock next-generation power sources like fusion and geothermal energy.
Kemper Corporation is set to report its fourth-quarter earnings Wednesday afternoon, with investors watching closely for signs of stability after a period of mixed performance and sector-wide pressure.
The pharmaceutical giant is set to release quarterly results before the bell Wednesday, with Wall Street anticipating another period of blockbuster revenue growth driven by its GLP-1 drugs.
Markel Group is set to report its latest quarterly earnings after the bell Wednesday. Investors will be watching to see if the insurer can build on last quarter's strong performance amid a challenging market for property and casualty stocks.
Decentralized exchange Hyperliquid has unveiled a proposal to launch 'outcome trading,' a novel, fully-collateralized contract type designed to power prediction markets and bounded options, positioning itself amid a regulatory shift and growing competition in the event-based trading sector.
Beyond its commercial applications, Iridium Communications Inc.'s (IRDM) resilient satellite constellation is being viewed as a critical asset for modern defense architectures, driving renewed investor interest despite recent stock volatility.
With its trust fund projected to be depleted by 2032, the Social Security program faces a pivotal moment. Congress must enact reforms within the next seven years to prevent automatic, across-the-board benefit reductions for millions of Americans.
A sophisticated zero-cost options trade by a large investor highlights a turning point for Hawaiian Electric Industries, as stabilized finances and capped liabilities pave the way for recovery.
NVR's shares have climbed to over $7,700, buoyed by recent gains. Yet, this short-term momentum sits alongside a flat one-year return, raising questions about whether the homebuilder's premium valuation is justified in the face of a cooling housing market.
Greg Abel's first major move as Berkshire Hathaway CEO involves reviewing a full exit from the Kraft Heinz stake, marking a potential departure from Warren Buffett's famed 'buy and hold' philosophy and testing investor confidence in the new leadership era.
Johnson & Johnson's oncology portfolio gains momentum with new clinical data for prostate cancer drug Erleada and a broader FDA label for multiple myeloma therapy Darzalex Faspro, reinforcing its competitive stance in key cancer markets.
With interest rate cuts on the horizon, America's largest homebuilder, D.R. Horton, is positioned to capitalize on pent-up demand from millennials and a potential housing market recovery, presenting a compelling value case for patient investors.
As AI infrastructure scales, reliability becomes paramount. Credo Technology Group, once a niche connectivity player, is now seeing explosive growth as its solutions become critical to preventing costly failures in hyperscale data centers. With revenue soaring over 270% and margins expanding, the debate is whether Credo is a cyclical beneficiary or the foundational 'toll road' of modern AI computing.
A deep dive into the bullish investment thesis for Inter & Co (INTR), which argues the integrated financial platform is significantly undervalued compared to regional giant Nubank, with its ambitious growth plan setting the stage for potential upside.
Amid a volatile market, specialty insurer Palomar Holdings (PLMR) presents a compelling growth story. With a disciplined underwriting strategy, robust risk management, and a track record of doubling profits every few years, the company trades at multiples that may significantly undervalue its consistent execution and expansion potential.
Emerging from bankruptcy ashes, the 52-year-old Bed Bath & Beyond brand is executing a radical pivot, acquiring Tokens.com to build a platform for tokenized real estate and asset-backed finance—a stark departure from its big-box retail roots.
HCA Healthcare, the nation's largest hospital operator, is navigating post-pandemic challenges with a strategy focused on operational efficiency and technology adoption. As labor costs moderate, analysts point to significant margin expansion potential driven by AI deployment across its vast network.
Insulet Corporation (NASDAQ: PODD), the maker of the tubeless Omnipod insulin delivery system, is drawing investor attention with a potent mix of surging cash flow, market expansion, and a recurring revenue model. As the company capitalizes on recent regulatory wins and international growth, we examine the bull case and the risks ahead.
